This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

---

---

Rosiglitazone

AVANDAMET, AVANDARYL, AVANDIA – GlaxoSmithKline Inc. (NOC Search)

Patents:

• 1328452: PHARMASCIENCE

PHARMASCIENCE

• PM(NOC) – T-1687-09 (2011 FC 239, 2011 FC 306, 2011 CF 306)
• Appeal – A-129-11

---

Return to the Patented Medicine Litigation page.